PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Prescription Opioids are Needed to Quell the Opioid Crisis

Prescription opioids needed to combat opioid crisis

This week Purdue Pharma settled with the state of Oklahoma for $270 million to avoid a trial charging the company with what I call opioid drug dealing. Purdue Pharma and members of the Sackler family–founders and managers of the company–are enmeshed in 1,600 cases throughout the U.S. They are accused of illegal marketing activities that led to over-prescribing and rampant distribution of Oxycontin, which paved the way for millions to the addiction of opioids, with hundreds of thousands dying over the last decade.

It was not just Purdue but many drug companies—and the entire drug supply chain—that fueled the opioid death spiral. As drug companies and their allies in the drug supply chain continue to use the opioid crisis as a means to oppose prescription drug importation to lower drug prices in the U.S., we can only look on with amazement at their audacity.

Tagged with: , ,

Freeh Group International Addendum on Drug Import Proposals

Earlier this week, a report (the “FGI Report”) opposing prescription drug importation proposals was released by the law firm of Freeh, Sporkin and Sullivan LLP and the Freeh Group International. Both organizations are headed by former FBI Director, Louis Freeh. I’m hesitant to criticize reports authored by dedicated Americans who spent years in public service protecting the safety of the American people in federal law enforcement. On the other hand, the intent of tacking the name of a venerated American patriot on a report that mirrors the lobbying agenda of the pharmaceutical industry is clearly being used to deter voices opposed to that agenda.

Summing it all up: this report was commissioned, I believe, by the drug company-funded group Partnership for Safe Medicines or a similar organization. As noted in the report’s title, it’s an addendum to an earlier report published in late 2017, one that was promoted at a Partnership for Safe Medicines media event at the National Press Club.

Tagged with: , , ,

Consumer Reports’ Deafening Silence about Safe Foreign Online Pharmacies

Consumer Reports' silence

Back in 2008, Consumer Reports recommended PharmacyChecker to Americans looking to save money on prescription drugs at foreign pharmacies. An article in the Los Angeles Times stated: “Consumer Reports Best Buy Drugs advises checking online prices, for U.S. and foreign pharmacies, at”

That was then. This is now.

When Consumer Reports’ Lisa Gill testified before the Senate Special Committee on Aging hearing on drug prices last week, she was silent in her prepared remarks about what she knows well: millions of Americans, readers of Consumer Reports, buy medicine online internationally. Her silence did not surprise me because Consumer Reports does not currently recommend buying medicine online from Canada or other countries, although many of its readers believe it should.

Tagged with: ,